deltatrials
Completed OBSERVATIONAL NCT04566562

Blood Brain Barrier Dysfunction and Postoperative Neurocognitive Disorders (BBBSx)

Blood Brain Barrier Dysfunction and Postoperative Neurocognitive Disorders in Older Adults

Sponsor: University of California, Los Angeles

Updated 8 times since 2020 Last updated: Dec 5, 2024 Started: Aug 3, 2020 Primary completion: Jan 30, 2024 Completion: Feb 29, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Neurocognitive Disorders and Postoperative Cognitive Dysfunction, this trial is completed. The trial is conducted by University of California, Los Angeles and has accumulated 8 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Oct 2020 – ~Jan 2021 · 3 months · monthly snapshotRecruiting~Jan 2021 – ~Oct 2021 · 9 months · monthly snapshotRecruiting~Oct 2021 – ~Jan 2023 · 15 months · monthly snapshotRecruiting~Jan 2023 – ~Sep 2023 · 8 months · monthly snapshotRecruiting~Sep 2023 – ~Jul 2024 · 10 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotRecruiting~Sep 2024 – ~Jan 2025 · 4 months · monthly snapshotRecruiting~Jan 2025 – present · 18 months · monthly snapshotCompleted

Change History

8 versions recorded
  1. Jan 2025 — Present [monthly]

    Completed

    Status: RecruitingCompleted

  2. Sep 2024 — Jan 2025 [monthly]

    Recruiting

  3. Jul 2024 — Sep 2024 [monthly]

    Recruiting

  4. Sep 2023 — Jul 2024 [monthly]

    Recruiting

  5. Jan 2023 — Sep 2023 [monthly]

    Recruiting

Show 3 earlier versions
  1. Oct 2021 — Jan 2023 [monthly]

    Recruiting

  2. Jan 2021 — Oct 2021 [monthly]

    Recruiting

  3. Oct 2020 — Jan 2021 [monthly]

    Recruiting

    First recorded

Aug 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • University of California, Los Angeles
Data source: University of California, Los Angeles

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations